Talecris Biotherapeutics today announced the recipients of the 2006 European Alpha-1 Antitrypsin Laurell’s Training Awards (eALTA). The recipients, from Pavia, Italy, and Marburg, Germany, were honored during the 2006 European Respiratory Society’s (ERS) Annual Congress in Munich, Germany, at a special symposium entitled “Alpha-1-Antitrypsin Deficiency - New Ways to the Understanding of a Rare Disease,” which included presentations from the 2005 eALTA awardees on their research projects. Talecris, manufacturer of Prolastin(R) (Alpha-1 Proteinase Inhibitor (Human)), which is licensed and sold in North America and several European countries for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1), provides funding for these annual fellowship awards.
